시장보고서
상품코드
2130577

첨단 혈액 분석 기기 시장 분석 및 예측(-2035년) : 유형, 제품, 기술, 구성 요소, 용도, 최종 사용자, 기능, 설치 유형, 기기, 솔루션

Advanced Blood Analysis Devices Market Analysis and Forecast to 2035: Type, Product, Technology, Component, Application, End User, Functionality, Installation Type, Equipment, Solutions

발행일: | 리서치사: 구분자 Global Insight Services | 페이지 정보: 영문 350 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



가격
PDF & Excel (Single User License) help
PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF, Excel 이용 범위와 동일합니다.
US $ 4,750 금액 안내 화살표 ₩ 6,507,000
PDF & Excel (Site License) help
PDF, Excel 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다.
US $ 5,750 금액 안내 화살표 ₩ 7,878,000
PDF & Excel (Enterprise License) help
PDF, Excel 보고서를 동일 기업의 전 세계 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF, Excel 이용 범위와 동일합니다.
US $ 6,750 금액 안내 화살표 ₩ 9,248,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 첨단 혈액 분석 기기 시장은 2025년 1,055억 달러에서 2035년까지 2,056억 달러로 확대되어 CAGR은 6.9%를 나타낼 것으로 예측됩니다. 첨단 혈액 분석 기기 시장은 보다 신속한 진단 검사에 대한 필요성, 고정밀 혈액 분석에 대한 수요 증가, 자동화 및 현장 진단(POC) 검사 기술의 발전에 힘입어 성장하고 있습니다. 미국 질병통제예방센터(CDC)의 2025 회계연도 ‘검사 과학 부문’ 보고서에 따르면, CDC 검사실은 리소좀 축적증 신생아 선별 검사에서 중요한 공정을 18시간에서 3시간으로 단축하는 새로운 분석법을 개발하여 당일 내 분석 및 결과 보고를 가능하게 했습니다. 자동 혈액 분석기, 질량 분석법, 분자진단, 바이오센서, 마이크로플루이딕스 플랫폼의 발전으로 혈액 검사의 속도와 범위가 향상되고 있습니다. 또한, 자동화와 디지털 데이터 시스템의 통합도 표준화된 고처리량 분석을 뒷받침하고 있습니다.

첨단 혈액 분석 기기 시장의 ‘유형’ 부문에는 벤치탑형 분석기, 휴대용 분석기, 핸드헬드형 분석기 등이 포함됩니다. 2025년에는 벤치탑형 분석기가 가장 큰 시장 점유율을 차지했습니다. 이는 높은 분석 능력, 폭넓은 검사 기능, 병원 및 진단실험실에서의 혈액가스, 전해질, 혈액학, 응고 및 기타 고급 분석에 대한 광범위한 활용에 힘입은 결과입니다. 휴대용 분석기는 현장 검사(Point-of-Care), 분산형 진단, 신속한 임상 의사 결정, 기존 검사실 외에서의 검사에 대한 수요 증가를 배경으로, 예측 기간 동안 가장 빠르게 성장할 부문이 될 것으로 예측됩니다. 또한, 컴팩트한 크기와 신속한 검사가 중요시되는 분야에서는 핸드헬드 분석기의 도입도 확대되고 있습니다.

첨단 혈액 분석 기기 시장의 최종 사용자 부문에는 병원, 진단실험실, 연구소, 재택 간호 시설 및 기타가 포함됩니다. 2025년에는 검사 건수가 많고, 응급 의료, 중환자 치료, 외과 수술 및 일상적인 진단에서 신속한 혈액 분석에 대한 수요가 증가함에 따라 병원이 가장 큰 점유율을 차지했습니다. 재택 간호 환경은 원격 환자 모니터링, 분산형 검사, 만성 질환 관리, 소형 혈액 분석 기술의 확대에 힘입어 예측 기간 동안 가장 빠르게 성장하는 부문이 될 것으로 예측됩니다. 진단실험실은 검사 역량 덕분에 계속해서 주요 사용자일 것이며, 한편 연구소는 생의학 및 임상 연구를 위해 고급 분석 기기를 활용하고 있습니다.

지역별 개요

2025년, 북미는 첨단 혈액 분석 기기 시장에서 가장 큰 점유율을 차지했습니다. 이는 첨단 진단 인프라, 검사실 자동화 도입률이 높고, 신속하고 정확한 혈액 검사에 대한 강력한 수요가 뒷받침된 결과입니다. 미국은 계속해서 주요 수요원으로 남아 있으며, 병원, 진단실험실, 응급 의료시설에서 자동 혈액학 분석 기기, 혈액가스 분석 기기, 현장 진단(POC) 시스템의 도입이 확대되고 있습니다. 진단 검사 건수의 많음, 확립된 의료 네트워크, 그리고 주요 의료기기 제조업체의 존재가 이 지역 수요를 더욱 강화하고 있습니다. 또한, 인공지능(AI), 자동화, 디지털 검사실 연계의 통합이 진행되고 있는 점도 임상 및 연구 현장에서의 첨단 혈액 분석 기술 도입을 뒷받침하고 있습니다.

아시아태평양은 예측 기간 동안 첨단 혈액 분석 기기 시장에서 가장 빠른 성장을 이룰 것으로 예측됩니다. 이러한 성장은 의료 인프라 확충, 진단 검사 건수 증가, 의료비 확대, 자동화된 검사 기술의 보급에 의해 주도되고 있습니다. 중국과 인도가 주요 견인차 역할을 하는 한편, 일본과 한국도 첨단 진단 시스템에 대한 수요를 지속적으로 뒷받침하고 있습니다. 혈액 질환, 감염증, 만성 질환에 대한 선별 검사 프로그램의 확대는 고급 분석 기기에 더 많은 기회를 창출하고 있습니다. 민간 진단 검사 기관에 대한 투자 확대, 병원의 현대화, 현장 진단(Point-of-Care) 검사, AI를 활용한 혈액 분석에 대한 투자 증가로 인해, 이 지역의 신흥 시장 및 선진 시장에서 도입이 더욱 가속화될 것으로 예측됩니다.

주요 동향 및 성장 촉진요인

자동화 및 현장(Point-of-Care) 혈액 분석의 보급 확대 :

첨단 혈액 분석 기기 시장의 주요 동향 중 하나는 혈액 검체 분석을 신속하게 하는 자동화, 소형화, 현장진단(POC) 기술의 도입 확대입니다. 첨단 기기에는 마이크로플루이딕스 기술, 바이오센서,자동화, 디지털 연결 기능이 통합되어 있어, 더 적은 양의 검체로 수작업 개입을 최소화하면서 여러 검사를 수행할 수 있게 되었습니다. 현장진단(POC) 시스템은 병원, 진료소, 응급실, 분산형 의료 현장 등에서 환자의 바로 곁에서 진단 정보를 제공할 수 있기 때문에 특히 그 중요성이 커지고 있습니다. 디지털 헬스 플랫폼 및 검사 정보 시스템(LIS)과의 통합을 통해 데이터 관리가 더욱 개선되고, 더 신속하며 협력이 강화되고 분산화가 진행되는 혈액 검사 워크플로우로의 전환이 촉진되고 있습니다.

신속하고 정확한 혈액 진단에 대한 수요 증가 :

첨단 혈액 분석 기기 시장의 주요 성장 촉진요인 중 하나는 모든 의료 현장에서 신속하고 정확하며 효율적인 혈액 진단 검사에 대한 수요가 증가하고 있다는 점입니다. 혈액 분석은 감염증, 대사성 질환, 심혈관 질환, 혈액 질환 및 기타 건강 상태의 확인과 모니터링에 중요한 역할을 하고 있습니다. 의료 서비스 제공업체들은 증가하는 검사량을 처리하면서도 수작업을 최소화하고, 신뢰할 수 있는 결과를 신속하게 제공할 수 있는 기술을 점점 더 요구하고 있습니다. 질병의 조기 발견에 대한 수요 증가, 현장 진단(Point-of-Care) 검사 확대, 만성 질환 모니터링 증가, 검사실 효율성 향상에 대한 필요성이 병원, 진단실험실 및 기타 의료 제공업체들에게 첨단 혈액 분석 기기 도입을 촉진하고 있습니다.

목차

제1장 주요 요약

제2장 시장 하이라이트

제3장 시장 역학

제4장 부문별 분석

제5장 지역별 분석

제6장 시장 전략

제7장 경쟁 정보

제8장 기업 개요

제9장 회사 소개

KTH 26.09.28

The global Advanced Blood Analysis Devices Market is projected to grow from $105.5 billion in 2025 to $205.6 billion by 2035, at a compound annual growth rate (CAGR) of 6.9%. The Advanced Blood Analysis Devices Market is driven by the need for faster diagnostic testing, increasing demand for high-accuracy blood analysis, and advances in automated and point-of-care laboratory technologies. According to the CDCs FY 2025 Division of Laboratory Sciences report, CDC laboratories developed a new analytical method that reduced a critical step in newborn screening for lysosomal storage disorders from 18 hours to 3 hours, enabling same-day analysis and reporting. Advances in automated hematology analyzers, mass spectrometry, molecular diagnostics, biosensors, and microfluidic platforms are improving the speed and range of blood testing. Integration of automation and digital data systems is also supporting standardized, high-throughput analysis.

The Type segment of the Advanced Blood Analysis Devices Market includes Benchtop Analyzers, Portable Analyzers, Handheld Analyzers, and Others. Benchtop Analyzers held the largest share in 2025, supported by their high analytical capacity, broader testing capabilities, and extensive use in hospitals and diagnostic laboratories for blood gas, electrolyte, hematology, coagulation, and other advanced analyses. Portable Analyzers are expected to be the fastest-growing segment during the forecast period, driven by increasing demand for point-of-care testing, decentralized diagnostics, faster clinical decision-making, and testing outside conventional laboratories. Handheld analyzers are also gaining adoption where compact size and rapid testing are important.

Market Segmentation
TypeBenchtop Analyzers, Portable Analyzers, Handheld Analyzers, Others
ProductBlood Gas Analyzers, Electrolyte Analyzers, Glucose Analyzers, Coagulation Analyzers, Hematology Analyzers, Immunoassay Analyzers, Others
TechnologySpectroscopy, Flow Cytometry, Chromatography, Electrophoresis, Microfluidics, Others
ComponentSensors, Reagents, Software, Others
ApplicationDisease Diagnosis, Therapeutic Monitoring, Research Applications, Others
End UserHospitals, Diagnostic Laboratories, Research Institutes, Home Care Settings, Others
FunctionalityAutomated, Semi-automated, Manual, Others
Installation TypeFixed, Mobile, Others
EquipmentSingle-Use Devices, Reusable Devices, Others
SolutionsPoint-of-Care Testing, Centralized Laboratory Testing, Others

The End User segment of the Advanced Blood Analysis Devices Market includes Hospitals, Diagnostic Laboratories, Research Institutes, Home Care Settings, and Others. Hospitals held the largest share in 2025, owing to high testing volumes and the need for rapid blood analysis across emergency care, intensive care, surgery, and routine diagnostics. Home Care Settings are expected to be the fastest-growing segment during the forecast period, supported by the expansion of remote patient monitoring, decentralized testing, chronic disease management, and compact blood-analysis technologies. Diagnostic laboratories remain major users because of their testing capacity, while research institutes utilize advanced analyzers for biomedical and clinical research.

Geographical Overview

North America held the largest share of the Advanced Blood Analysis Devices Market in 2025, supported by advanced diagnostic infrastructure, high laboratory automation adoption, and strong demand for rapid and accurate blood testing. The U.S. remained the primary contributor, with hospitals, diagnostic laboratories, and emergency-care facilities increasingly adopting automated hematology analyzers, blood gas analyzers, and point-of-care testing systems. High diagnostic testing volumes, established healthcare networks, and the presence of leading medical-device manufacturers further strengthen regional demand. Increasing integration of artificial intelligence, automation, and digital laboratory connectivity is also supporting the adoption of advanced blood analysis technologies across clinical and research settings.

Asia Pacific is expected to be the fastest-growing region in the Advanced Blood Analysis Devices Market during the forecast period. Growth is being driven by expanding healthcare infrastructure, rising diagnostic testing volumes, increasing healthcare expenditure, and greater adoption of automated laboratory technologies. China and India are key contributors, while Japan and South Korea continue to support demand for sophisticated diagnostic systems. Growing screening programs for blood disorders, infectious diseases, and chronic conditions are creating additional opportunities for advanced analyzers. Increasing investments in private diagnostic laboratories, hospital modernization, point-of-care testing, and AI-enabled blood analysis are expected to further accelerate adoption across emerging and developed markets in the region.

Key Trends and Drivers

Increasing Adoption of Automated and Point-of-Care Blood Analysis:

A key trend in the advanced blood analysis devices market is the increasing adoption of automated, miniaturized, and point-of-care technologies that enable faster analysis of blood samples. Advanced devices are incorporating microfluidics, biosensors, automation, and digital connectivity to perform multiple tests with smaller sample volumes and reduced manual intervention. Point-of-care systems are particularly gaining importance because they can provide diagnostic information closer to patients in hospitals, clinics, emergency departments, and decentralized healthcare settings. Integration with digital health platforms and laboratory information systems is further improving data management, supporting a shift toward faster, more connected, and increasingly decentralized blood testing workflows.

Growing Need for Rapid and Accurate Blood-Based Diagnostics:

A key driver of the advanced blood analysis devices market is the growing need for rapid, accurate, and efficient blood-based diagnostic testing across healthcare settings. Blood analysis plays an important role in identifying and monitoring infections, metabolic disorders, cardiovascular conditions, hematological diseases, and other health conditions. Healthcare providers increasingly require technologies that can deliver reliable results quickly while handling growing testing volumes and minimizing manual processing. Rising demand for early disease detection, expansion of point-of-care testing, increasing chronic disease monitoring, and the need to improve laboratory efficiency are encouraging hospitals, diagnostic laboratories, and other healthcare providers to adopt advanced blood analysis devices.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Technology
  • 2.4 Key Market Highlights by Component
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Functionality
  • 2.8 Key Market Highlights by Installation Type
  • 2.9 Key Market Highlights by Equipment
  • 2.10 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Benchtop Analyzers
    • 4.1.2 Portable Analyzers
    • 4.1.3 Handheld Analyzers
    • 4.1.4 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Blood Gas Analyzers
    • 4.2.2 Electrolyte Analyzers
    • 4.2.3 Glucose Analyzers
    • 4.2.4 Coagulation Analyzers
    • 4.2.5 Hematology Analyzers
    • 4.2.6 Immunoassay Analyzers
    • 4.2.7 Others
  • 4.3 Market Size & Forecast by Technology (2020-2035)
    • 4.3.1 Spectroscopy
    • 4.3.2 Flow Cytometry
    • 4.3.3 Chromatography
    • 4.3.4 Electrophoresis
    • 4.3.5 Microfluidics
    • 4.3.6 Others
  • 4.4 Market Size & Forecast by Component (2020-2035)
    • 4.4.1 Sensors
    • 4.4.2 Reagents
    • 4.4.3 Software
    • 4.4.4 Others
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Disease Diagnosis
    • 4.5.2 Therapeutic Monitoring
    • 4.5.3 Research Applications
    • 4.5.4 Others
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Hospitals
    • 4.6.2 Diagnostic Laboratories
    • 4.6.3 Research Institutes
    • 4.6.4 Home Care Settings
    • 4.6.5 Others
  • 4.7 Market Size & Forecast by Functionality (2020-2035)
    • 4.7.1 Automated
    • 4.7.2 Semi-automated
    • 4.7.3 Manual
    • 4.7.4 Others
  • 4.8 Market Size & Forecast by Installation Type (2020-2035)
    • 4.8.1 Fixed
    • 4.8.2 Mobile
    • 4.8.3 Others
  • 4.9 Market Size & Forecast by Equipment (2020-2035)
    • 4.9.1 Single-Use Devices
    • 4.9.2 Reusable Devices
    • 4.9.3 Others
  • 4.10 Market Size & Forecast by Solutions (2020-2035)
    • 4.10.1 Point-of-Care Testing
    • 4.10.2 Centralized Laboratory Testing
    • 4.10.3 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Technology
      • 5.2.1.4 Component
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Functionality
      • 5.2.1.8 Installation Type
      • 5.2.1.9 Equipment
      • 5.2.1.10 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Technology
      • 5.2.2.4 Component
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Functionality
      • 5.2.2.8 Installation Type
      • 5.2.2.9 Equipment
      • 5.2.2.10 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Technology
      • 5.2.3.4 Component
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Functionality
      • 5.2.3.8 Installation Type
      • 5.2.3.9 Equipment
      • 5.2.3.10 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Technology
      • 5.3.1.4 Component
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Functionality
      • 5.3.1.8 Installation Type
      • 5.3.1.9 Equipment
      • 5.3.1.10 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Technology
      • 5.3.2.4 Component
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Functionality
      • 5.3.2.8 Installation Type
      • 5.3.2.9 Equipment
      • 5.3.2.10 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Technology
      • 5.3.3.4 Component
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Functionality
      • 5.3.3.8 Installation Type
      • 5.3.3.9 Equipment
      • 5.3.3.10 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Technology
      • 5.4.1.4 Component
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Functionality
      • 5.4.1.8 Installation Type
      • 5.4.1.9 Equipment
      • 5.4.1.10 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Technology
      • 5.4.2.4 Component
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Functionality
      • 5.4.2.8 Installation Type
      • 5.4.2.9 Equipment
      • 5.4.2.10 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Technology
      • 5.4.3.4 Component
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Functionality
      • 5.4.3.8 Installation Type
      • 5.4.3.9 Equipment
      • 5.4.3.10 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Technology
      • 5.4.4.4 Component
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Functionality
      • 5.4.4.8 Installation Type
      • 5.4.4.9 Equipment
      • 5.4.4.10 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Technology
      • 5.4.5.4 Component
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Functionality
      • 5.4.5.8 Installation Type
      • 5.4.5.9 Equipment
      • 5.4.5.10 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Technology
      • 5.4.6.4 Component
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Functionality
      • 5.4.6.8 Installation Type
      • 5.4.6.9 Equipment
      • 5.4.6.10 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Technology
      • 5.4.7.4 Component
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Functionality
      • 5.4.7.8 Installation Type
      • 5.4.7.9 Equipment
      • 5.4.7.10 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Technology
      • 5.5.1.4 Component
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Functionality
      • 5.5.1.8 Installation Type
      • 5.5.1.9 Equipment
      • 5.5.1.10 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Technology
      • 5.5.2.4 Component
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Functionality
      • 5.5.2.8 Installation Type
      • 5.5.2.9 Equipment
      • 5.5.2.10 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Technology
      • 5.5.3.4 Component
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Functionality
      • 5.5.3.8 Installation Type
      • 5.5.3.9 Equipment
      • 5.5.3.10 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Technology
      • 5.5.4.4 Component
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Functionality
      • 5.5.4.8 Installation Type
      • 5.5.4.9 Equipment
      • 5.5.4.10 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Technology
      • 5.5.5.4 Component
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Functionality
      • 5.5.5.8 Installation Type
      • 5.5.5.9 Equipment
      • 5.5.5.10 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Technology
      • 5.5.6.4 Component
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Functionality
      • 5.5.6.8 Installation Type
      • 5.5.6.9 Equipment
      • 5.5.6.10 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Technology
      • 5.6.1.4 Component
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Functionality
      • 5.6.1.8 Installation Type
      • 5.6.1.9 Equipment
      • 5.6.1.10 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Technology
      • 5.6.2.4 Component
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Functionality
      • 5.6.2.8 Installation Type
      • 5.6.2.9 Equipment
      • 5.6.2.10 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Technology
      • 5.6.3.4 Component
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Functionality
      • 5.6.3.8 Installation Type
      • 5.6.3.9 Equipment
      • 5.6.3.10 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Technology
      • 5.6.4.4 Component
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Functionality
      • 5.6.4.8 Installation Type
      • 5.6.4.9 Equipment
      • 5.6.4.10 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Technology
      • 5.6.5.4 Component
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Functionality
      • 5.6.5.8 Installation Type
      • 5.6.5.9 Equipment
      • 5.6.5.10 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Abbott Laboratories
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Roche Diagnostics
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Siemens Healthineers
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Beckman Coulter
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Sysmex Corporation
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Horiba
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Bio-Rad Laboratories
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Instrumentation Laboratory
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Nova Biomedical
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Radiometer Medical
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Mindray Medical International
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Thermo Fisher Scientific
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Becton Dickinson
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 PerkinElmer
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 HemoCue
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Alere
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Ortho Clinical Diagnostics
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Randox Laboratories
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 EKF Diagnostics
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Meril Life Sciences
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기